0001193125-26-056502
SEC filingInnospec Inc. reported net sales of $1.78 billion for fiscal year 2025, generating a gross profit of $492.4 million. Operating income was $129.5 million, and net income reached $116.6 million, translating to earnings per share of $5.00 (both basic and diluted). The company's balance sheet shows total assets of $1.83 billion, with strong liquidity including $292.5 million in cash and cash equivalents and total current assets of $1.00 billion. Total liabilities were $499.5 million, resulting in total equity of $1.33 billion. Cash flow from operations was $138.3 million, while investing activities used $75.1 million primarily for capital expenditures and internally developed software. Financing activities used $63.9 million for dividends and share repurchases. The company ended the year with $147.1 million in cash and cash equivalents.
Innospec Inc. reported fiscal year 2025 results with net sales of $1.78 billion. The company achieved gross profit of $492.4 million, representing a gross margin of 27.7%. Operating income was $129.5 million (7.3% operating margin), while net income reached $116.6 million. Earnings per share were $5.00 for both basic and diluted calculations. The company maintained strong financial discipline with operating cash flow of $138.3 million, which exceeded net income due to non-cash adjustments including depreciation and amortization of $43.6 million and impairment charges totaling $42.0 million for property, plant, equipment, and intangible assets.
The filing provides consolidated revenue figures without segment breakdown. Net sales of $1.78 billion represent the company's total revenue across all business operations. No geographic mix or segment-specific revenue data is disclosed in the provided financial data. The company's revenue generation appears to be diversified across its operations, though specific drivers of revenue growth or decline are not detailed in the available information. The absence of segment reporting suggests either consolidated operations or insufficient disclosure requirements for segment reporting in this filing.
The company achieved a gross margin of 27.7% on $1.78 billion in sales, with cost of goods sold totaling $1.29 billion. Operating margin was 7.3%, reflecting operating expenses of $362.9 million which included selling, general and administrative expenses of $285.1 million, research and development of $51.0 million, restructuring charges of $900,000, and impairment charges totaling $42.0 million. The adjustment to fair value of contingent consideration provided a benefit of $15.9 million. Net income margin was 6.6%, with income tax expense of $21.5 million representing an effective tax rate of approximately 15.6%.
Operating activities generated $138.3 million in cash, driven by net income of $116.6 million adjusted for non-cash items. Investing activities used $75.1 million primarily for capital expenditures ($50.3 million) and internally developed software ($25.2 million). Financing activities used $63.9 million for dividend payments ($42.4 million) and share repurchases ($23.9 million). The balance sheet shows strong liquidity with $292.5 million in cash and cash equivalents, total current assets of $1.00 billion, and current liabilities of $360.1 million, resulting in a current ratio of approximately 2.8. Total assets of $1.83 billion include goodwill of $399.0 million and net property, plant and equipment of $286.1 million. Total equity of $1.33 billion includes retained earnings of $1.10 billion.
The filing does not contain specific forward-looking guidance, management projections, or explicit strategic priorities for future periods. No quantitative or qualitative outlook information is provided in the available financial data. Risk factors and future expectations typically found in MD&A sections are not included in the provided content. Investors should refer to the complete 10-K filing for comprehensive discussion of future plans, risk factors, and management's expectations, as the provided data focuses exclusively on historical financial results for fiscal year 2025.